Group One Trading
RXDX

Group One Trading’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History

Group One Trading’s Portfolio RXDX Stock Details RXDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-15,600
Closed -$1.67M – 8432
2023
Q1 		$1.67M Sell
15,600
-104,100
-87% -$12M 0.01% 1685
2022
Q4 		$13.2M Buy
+119,700
New +$7.76M 0.03% 586

Other funds holding RXDX

UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
FCA
FinTrust Capital Advisors Greenville, South Carolina $591M AUM 26.89% 1-Year Est. Return

Group One Trading's RXDX Position: Q2 2023 in Review

Group One Trading sold out of Prometheus Biosciences, Inc. Common Stock (RXDX) in Q2 2023, closing a stake of 2,421 shares — an estimated $260K sold.

Group One Trading first reported a position in RXDX in Q1 2023 and held it in 1 quarter. The position peaked at $260K in Q1 2023. 2 funds tracked by Wall St. Rank hold RXDX as of Q2 2023.

  • Group One Trading reported no remaining Prometheus Biosciences, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Group One Trading sold 2,421 Prometheus Biosciences, Inc. Common Stock shares in Q2 2023, an estimated $260K.
  • Group One Trading first reported a position in Prometheus Biosciences, Inc. Common Stock in Q1 2023 and held it in 1 quarter.
  • Group One Trading's Prometheus Biosciences, Inc. Common Stock position peaked at $260K in Q1 2023.
  • 2 funds tracked by Wall St. Rank held Prometheus Biosciences, Inc. Common Stock as of Q2 2023.

Based on Group One Trading's 13F filing for Q2 2023, filed 9 Aug 2023.